[go: up one dir, main page]

NO20024576L - Fremgangsmate for a inhibere angiogenese og tumorvekst - Google Patents

Fremgangsmate for a inhibere angiogenese og tumorvekst

Info

Publication number
NO20024576L
NO20024576L NO20024576A NO20024576A NO20024576L NO 20024576 L NO20024576 L NO 20024576L NO 20024576 A NO20024576 A NO 20024576A NO 20024576 A NO20024576 A NO 20024576A NO 20024576 L NO20024576 L NO 20024576L
Authority
NO
Norway
Prior art keywords
tumor growth
inhibiting angiogenesis
angiogenesis
inhibiting
tumor
Prior art date
Application number
NO20024576A
Other languages
English (en)
Other versions
NO20024576D0 (no
Inventor
Dale L Boger
David A Cheresh
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20024576D0 publication Critical patent/NO20024576D0/no
Publication of NO20024576L publication Critical patent/NO20024576L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
NO20024576A 2000-03-27 2002-09-24 Fremgangsmate for a inhibere angiogenese og tumorvekst NO20024576L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27
PCT/US2001/009785 WO2001072297A1 (en) 2000-03-27 2001-03-27 Methods for inhibiting angiogenesis and tumor growth

Publications (2)

Publication Number Publication Date
NO20024576D0 NO20024576D0 (no) 2002-09-24
NO20024576L true NO20024576L (no) 2002-11-20

Family

ID=22708924

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20024578A NO328969B1 (no) 2000-03-27 2002-09-24 Forbindelser, sammensetninger og anvendelser derav
NO20024576A NO20024576L (no) 2000-03-27 2002-09-24 Fremgangsmate for a inhibere angiogenese og tumorvekst

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20024578A NO328969B1 (no) 2000-03-27 2002-09-24 Forbindelser, sammensetninger og anvendelser derav

Country Status (15)

Country Link
EP (2) EP1276713A4 (no)
JP (2) JP2003528850A (no)
KR (2) KR100776185B1 (no)
CN (2) CN1229339C (no)
AU (4) AU5101801A (no)
CA (3) CA2403871C (no)
CZ (2) CZ20023509A3 (no)
HU (2) HUP0301621A3 (no)
MX (2) MXPA02009510A (no)
NO (2) NO328969B1 (no)
PL (2) PL205134B1 (no)
RU (2) RU2276133C2 (no)
SK (2) SK14842002A3 (no)
WO (2) WO2001072699A1 (no)
ZA (2) ZA200208628B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2235611B2 (es) * 2003-07-25 2006-07-16 Universidade De Santiago De Compostela Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas.
CA2543242C (en) 2003-10-23 2015-04-14 Otsuka Pharmaceutical Co., Ltd. Controlled release sterile freeze-dried aripiprazole formulation and injectable formulation thereof
RU2287341C1 (ru) * 2005-03-01 2006-11-20 Автономная некоммерческая организация Научно-технический центр "Фармбиопресс" Ингибитор ангиогенеза, антиангиогенная фармацевтическая композиция на его основе и способ лечения злокачественных новообразований
PT2170279T (pt) 2007-07-31 2018-04-06 Otsuka Pharma Co Ltd Métodos para produção de suspensão de aripiprazole e formulação liofilizada
RU2404794C2 (ru) * 2008-11-27 2010-11-27 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) Вагинальные суппозитории для лечения рака шейки матки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
PL181749B1 (pl) * 1993-10-15 2001-09-28 Aventis Pharm Prod Inc Zwiazek do zapobiegania i leczenia zakrzepicy u ssaków oraz oraz kompozycja farmaceutyczna do zapobiegania i leczenia zakrzepicy u ssaków PL PL PL PL PL PL PL PL
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
JP2002514180A (ja) * 1996-09-04 2002-05-14 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法
AU736264B2 (en) * 1997-02-07 2001-07-26 Scripps Research Institute, The Convergent synthesis of combinatorial library
WO1999049856A2 (en) * 1998-03-27 1999-10-07 Genentech, Inc. Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders

Also Published As

Publication number Publication date
HUP0301621A3 (en) 2009-06-29
CA2403630C (en) 2009-05-26
HUP0301621A2 (hu) 2003-09-29
CN1429106A (zh) 2003-07-09
CA2403871C (en) 2010-05-11
EP1272173A1 (en) 2003-01-08
AU5101801A (en) 2001-10-08
ZA200208628B (en) 2004-02-12
JP2003528850A (ja) 2003-09-30
KR20020084258A (ko) 2002-11-04
KR100767616B1 (ko) 2007-10-18
HUP0301797A3 (en) 2010-09-28
CZ20023510A3 (cs) 2003-03-12
CA2403630A1 (en) 2001-10-04
RU2002128751A (ru) 2004-03-10
ZA200208626B (en) 2004-02-16
AU4949901A (en) 2001-10-08
CA2659030A1 (en) 2001-10-04
RU2276133C2 (ru) 2006-05-10
WO2001072699A1 (en) 2001-10-04
KR100776185B1 (ko) 2007-11-16
PL358272A1 (en) 2004-08-09
NO20024578L (no) 2002-11-20
HUP0301797A2 (hu) 2003-09-29
JP2003528140A (ja) 2003-09-24
CN1245967C (zh) 2006-03-22
CN1441777A (zh) 2003-09-10
SK14852002A3 (sk) 2003-06-03
MXPA02009510A (es) 2003-05-21
KR20020091156A (ko) 2002-12-05
AU2001249499B2 (en) 2005-04-21
CZ20023509A3 (cs) 2003-06-18
SK14842002A3 (sk) 2003-04-01
EP1276713A1 (en) 2003-01-22
CN1229339C (zh) 2005-11-30
PL205134B1 (pl) 2010-03-31
NO328969B1 (no) 2010-06-28
RU2269339C2 (ru) 2006-02-10
WO2001072297A1 (en) 2001-10-04
MXPA02009504A (es) 2003-05-21
NO20024576D0 (no) 2002-09-24
PL366316A1 (en) 2005-01-24
CA2403871A1 (en) 2001-10-04
NO20024578D0 (no) 2002-09-24
EP1272173A4 (en) 2006-05-03
EP1276713A4 (en) 2006-05-03
AU2001251018B2 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
GB2376076B (en) Method and apparatus for cancellation of borehole effects due to a tilted or transverse magnetic dipole
NO20015547D0 (no) Halvsyntetisk fremgangsmåte og nye forbindelser
NO20022188L (no) Flerlagssikt og fremgangsmåte for nedihulls ferdigstilling
AU7692601A (en) Method for treating multiple wellbore intervals
NO20030200L (no) Fremgangsmåte og anordning for å plassere og utspörre nedihullssensorer
NO20014823L (no) Heterocyklus-holdige bifenyl-aP2-inhibitorer og metode
NO331217B1 (no) Fremgangsmate og anordning for nedihullsoperasjoner
EP1097165A4 (en) NEW INHIBITORS OF ANGIOGENESIS AND TUMOR GROWTH
NO20015764L (no) Fremgangsmåte og preparat for å maskere mineralsmak
GB2358962B (en) Method of using magnetic lifting devices
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20025094D0 (no) System og fremgangsmÕte for stigerör-tilbaketrekkingsstyring
NO20024576L (no) Fremgangsmate for a inhibere angiogenese og tumorvekst
PL346034A1 (en) Method of obtaining substituted banzoylcyanide aminohydrazones
ID30377A (id) Metoda pengobatan neurodegenerasi
NO20023959L (no) Flateelement og fremgangsmåte for fremstilling av et flateelement
IS2685B (is) Aðferð og búnaður fyrir botnnema
EP1267911A4 (en) TREATMENT METHOD
GB0008353D0 (en) Method of treating a parasitic infection
GB2371808B (en) Method of planting trees
NO20026067L (no) Systemer og fremgangsmåter for behandling av en slimhinneoverflate
GB0026834D0 (en) Method for detecting inhibitors of tumour growth
PL344620A1 (en) 1-alkoxymethyl-3-y-pyridinium salts and method of obtaining them _
AU3713201A (en) A method of treatment
NO20001694D0 (no) Vekstanordning for skjell og skalldyr

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application